Last updated on November 2017

A Randomized, double-blind, parallel-group, 12-week, chronic-dosing, multi-center study to assess the efficacy and safety of PT010 compared to PT009 in subjects with moderate to very severe chronic obstructive pulmonary disease (COPD).

Other Details:

Compensation is provided for your time and travel expenses.
For more information please contact our office at 636-946-1650.

Contact Investigators or Research Sites near you

Start Over

Mitchell Champagne, RPh, CCRC

Midwest Chest Consultants
St. Charles, MO USA